​

AxoGen (AXGN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

AXGN Stock Forecast

AxoGen (AXGN) stock forecast, based on 19 Wall Street analysts, predicts a 12-month average price target of $50.17, with a high of $55.00 and a low of $40.00. This represents a 21.33% increase from the last price of $41.35.

$5 $15 $25 $35 $45 $55 High: $55 Avg: $50.17 Low: $40 Last Closed Price: $41.35

AXGN Stock Rating

AxoGen stock's rating consensus is Buy, based on 19 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (84.21%), 3 Hold (15.79%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 19 0 3 16 Strong Sell Sell Hold Buy Strong Buy

AXGN Price Target Upside V Benchmarks

TypeNameUpside
StockAxoGen21.33%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.34%

Price Target Trends

1M3M12M
# Anlaysts3319
Avg Price Target$54.33$54.33$40.89
Last Closing Price$41.35$41.35$41.35
Upside/Downside31.39%31.39%-1.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2627---9
Jun, 2627---9
May, 2627---9
Apr, 2627---9
Mar, 2628---10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2026Yi ChenH.C. Wainwright$53.00$41.3728.11%28.17%
Jul 30, 2026Truist Financial$55.00$41.3732.95%33.01%
Jul 29, 2026Jefferies$55.00$41.3732.95%33.01%
Apr 29, 2026Raymond James$48.00$41.7914.86%16.08%
Apr 29, 2026Caitlin RobertsCanaccord Genuity$50.00$41.9919.08%20.92%
Apr 29, 2026H.C. Wainwright$50.00$41.9919.08%20.92%
Apr 24, 2026Canaccord Genuity$45.00$37.4120.29%8.83%
Feb 23, 2026Jayson BedfordRaymond James$41.00$35.0017.14%-0.85%
Feb 19, 2026Wells Fargo$40.00$35.2513.48%-3.26%
Dec 05, 2025H.C. Wainwright$39.00$33.7015.73%-5.68%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 30, 2026H.C. WainwrightBuyBuyhold
Jul 30, 2026CitigroupOutperformOutperformhold
Jul 30, 2026CitigroupMarket OutperformMarket Outperformhold
Jul 29, 2026JefferiesBuyBuyhold
Apr 29, 2026Raymond JamesOutperformOutperformhold
Apr 29, 2026H.C. WainwrightBuyBuyhold
Apr 29, 2026CitigroupOutperformOutperformhold
Feb 24, 2026CitigroupOutperformOutperformhold
Feb 23, 2026Raymond JamesOutperformOutperformhold
Feb 19, 2026Wells FargoOverweightinitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.65$-0.69$-0.51$-0.23$-0.34---
Avg Forecast$-0.45$-0.38$-0.18$0.08$0.32$0.50$0.80$1.03
High Forecast$-0.45$-0.38$-0.10$0.09$0.41$1.34$0.82$1.05
Low Forecast$-0.46$-0.39$-0.30$0.06$0.17$-0.03$0.79$1.01
Surprise %44.44%81.58%183.33%-387.50%-206.25%---

Revenue Forecast

$100M $150M $200M $250M $300M $350M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$127.36M$138.58M$159.01M$187.34M$225.21M---
Avg Forecast$127.56M$138.65M$157.75M$186.09M$210.10M$236.14M$271.40M$303.65M
High Forecast$128.93M$139.92M$160.54M$187.34M$212.44M$236.98M$275.90M$309.02M
Low Forecast$126.54M$137.46M$155.86M$184.84M$208.32M$235.30M$266.90M$300.02M
Surprise %-0.16%-0.05%0.80%0.67%7.19%---

Net Income Forecast

$-50M $-20M $10M $40M $70M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-26.98M$-28.95M$-21.72M$-9.96M$-15.70M---
Avg Forecast$-32.48M$-35.74M$-21.72M$3.12M$12.48M$18.07M$34.43M$44.16M
High Forecast$-25.98M$-28.59M$-17.37M$3.67M$17.52M$57.62M$35.09M$45.18M
Low Forecast$-38.97M$-42.89M$-26.06M$2.57M$7.45M$-1.46M$33.77M$43.48M
Surprise %-16.91%-19.01%--419.06%-225.80%---

AXGN Forecast FAQ

Is AxoGen stock a buy?

AxoGen stock has a consensus rating of Buy, based on 19 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AxoGen is a favorable investment for most analysts.

What is AxoGen's price target?

AxoGen's price target, set by 19 Wall Street analysts, averages $50.17 over the next 12 months. The price target range spans from $40 at the low end to $55 at the high end, suggesting a potential 21.33% change from the previous closing price of $41.35.

How does AxoGen stock forecast compare to its benchmarks?

AxoGen's stock forecast shows a 21.33% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.34%).

What is the breakdown of analyst ratings for AxoGen over the past three months?

  • July 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AxoGen’s EPS forecast?

AxoGen's average annual EPS forecast for its fiscal year ending in December 2026 is $0.5, marking a -247.06% decrease from the reported $-0.34 in 2025. Estimates for the following years are $0.8 in 2027, and $1.03 in 2028.

What is AxoGen’s revenue forecast?

AxoGen's average annual revenue forecast for its fiscal year ending in December 2026 is $236.14M, reflecting a 4.86% increase from the reported $225.21M in 2025. The forecast for 2027 is $271.4M, and $303.65M for 2028.

What is AxoGen’s net income forecast?

AxoGen's net income forecast for the fiscal year ending in December 2026 stands at $18.07M, representing a -215.09% decrease from the reported $-15.703M in 2025. Projections indicate $34.43M in 2027, and $44.16M in 2028.